A Japanese research team is making significant progress in developing a groundbreaking medication that may allow people to grow new teeth. Clinical trials for the tooth regrowth medicine are set to begin in July 2024, with the goal of having it ready for general use by 2030. The medication has already shown promising results in animal experiments, prompting the growth of “third-generation” teeth. Anodontia, a congenital condition that causes a partial or complete lack of teeth, affects approximately 1% of the population. The new medication could potentially revolutionize dentistry and provide an alternative to dentures and implants.
https://mainichi.jp/english/articles/20230609/p2a/00m/0sc/026000c